Track the Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Market capitalisation: €14.5bn. The latest transaction was filed on 10 July 2026 (Purchase). Among the most active insiders: Wang Philip Li. Every trade is free.
35
Insider Decl.
0
Thresholds
€1m
35 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Buys €1m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 11,539 of 26,220 companies
55.1
score / 100
Value
87
Quality
23
FCF yld38%
Earn yld8.3%
EV/EBITDA6.5x
ROE·
Gross mgn18%
Net mgn1.0%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10,000 shares@ €0.3440.0000% mcap0.3% of flowShareXHKGHKEX:DA20260604E00084
Ideal exit: 28 Feb 2027 (T+270)
25 of 35 declarations
About Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh
Shanghai Bio-heart Biological Technology Co., Ltd. is a company focused on the development of biological technologies. It specializes in the research and production of innovative biological products.